Table of Contents

• 1.1 List of Tables 10
• 1.2 List of Figures 18

2 Introduction 19

• 2.1 Cardiac Assist Devices Overview 19

3 Products under Development 20

• 3.1 Cardiac Assist Devices - Pipeline Products by Stage of Development 20
• 3.2 Cardiac Assist Devices - Pipeline Products by Segment 21
• 3.3 Cardiac Assist Devices - Pipeline Products by Territory 22
• 3.4 Cardiac Assist Devices - Pipeline Products by Regulatory Path 23
• 3.5 Cardiac Assist Devices - Pipeline Products by Estimated Approval Date 24
• 3.6 Cardiac Assist Devices - Ongoing Clinical Trials 25

4 Cardiac Assist Devices - Pipeline Products under Development by Companies 26

• 4.1 Cardiac Assist Devices Companies - Pipeline Products by Stage of Development 26
• 4.2 Cardiac Assist Devices - Pipeline Products by Stage of Development 30

5 Cardiac Assist Devices Companies and Product Overview 34

• 5.1 Abiomed Inc Company Overview 34
  • 5.1.1 Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 34
• 5.2 Acorn Cardiovascular, Inc. (Inactive) Company Overview 40
  • 5.2.1 Acorn Cardiovascular, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.3 Arrow International Cr, A.S. Company Overview 41
  • 5.3.1 Arrow International Cr, A.S. Pipeline Products & Ongoing Clinical Trials Overview 41
• 5.4 Berlin Heart GmbH Company Overview 42
  • 5.4.1 Berlin Heart GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
• 5.5 BioQ Devices Pty Ltd Company Overview 43
  • 5.5.1 BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.6 Biosurfaces Inc Company Overview 44
  • 5.6.1 Biosurfaces Inc Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.7 BioVentrix Inc Company Overview 45
  • 5.7.1 BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 45
• 5.8 BiVacor Pty Ltd Company Overview 48
  • 5.8.1 BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
• 5.9 Braile Biomedica Ltda Company Overview 49
  • 5.9.1 Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 49
• 5.10 Calon Cardio-Technology Ltd Company Overview 50
  • 5.10.1 Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
• 5.11 CardiacAssist Inc Company Overview 53
  • 5.11.1 CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 53
• 5.12 Cardiak Ltd. Company Overview 54
  • 5.12.1 Cardiak Ltd. Pipeline Products & Ongoing Clinical Trials Overview 54
• 5.13 CARDIAnove Inc Company Overview 55
  • 5.13.1 CARDIAnove Inc Pipeline Products & Ongoing Clinical Trials Overview 55
• 5.14 CardioBridge GmbH Company Overview 56
  • 5.14.1 CardioBridge GmbH Pipeline Products & Ongoing Clinical Trials Overview 56
• 5.15 Cardiovascular Systems Inc Company Overview 58
  • 5.15.1 Cardiovascular Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 58
• 5.16 Carmat SAS Company Overview 59
  • 5.16.1 Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 59
• 5.17 Carnegie Mellon University Company Overview 63
  • 5.17.1 Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 63
• 5.18 Cleveland Clinic Hospital Company Overview 65
  • 5.18.1 Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 65
• 5.19 Cleveland Clinic Lerner College of Medicine Company Overview 66
  • 5.19.1 Cleveland Clinic Lerner College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 66
• 5.20 Cleveland Heart Inc Company Overview 68
  • 5.20.1 Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 68

6 Cardiac Assist Devices- Recent Developments 205

• 6.1 Nov 27, 2019: CARMAT appoints Alexandre Eleonore as director of manufacturing 205
• 6.2 Nov 19, 2019: Impella heart pumps associated with complications after stent procedure 205
• 6.3 Nov 19, 2019: Abiomed Medical Office completes review of Observational Analysis of Impella Presented at AHA 206
• 6.4 Nov 19, 2019: CARMAT granted authorization to resume the PIVOTAL study in the Czech Republic 209
• 6.5 Nov 19, 2019: Update On Device Failure Associated with Getinge's Maquet/Datascope Intra-Aortic Balloon Pumps - Letter to Health Care Providers 210

7 Appendix 339

• 7.1 Methodology 339
• 7.2 About GlobalData 342
• 7.3 Contact Us 342

Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Cardiac Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiac Assist Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiac Assist Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiac Assist Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date